Immunome, Inc. (IMNM) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -28.95%. A quarter ago, it was expected that this company would post a loss of $0.80 per share when it actually produced a loss of $0.34, delivering a surprise of 57.50%. Over the last four quarters, the company has surpas ...